Sleeping Pill Withdrawal Symptoms
Symptoms of sleeping pill withdrawal will vary by the individual, particularly in cases of dual-diagnosis or co-occurring mental illnesses, which may require inpatient treatment and medical detox at a drug rehab center. It is advised that people with sleeping pill addictions seek professional drug treatment to monitor their withdrawal process in a safe environment.
For more information about prominent sleeping pill withdrawals, read the following pages:
- Ambien: Ambien is the brand name version of zolpidem and is regarded as a non-benzodiazepine sedative hypnotic. It’s one of the most popular sleeping pills and also the most abused sedative in the United States, with about 20,793 people being sent to the emergency room for zolpidem-related incidents, according to SAMHSA. Ambien addiction is often seen with other substance addictions, such as alcohol or Xanax, and can have intense withdrawal symptoms once a person decides to quit.
- Sonata: Zaleplon, known by its brand name Sonata, is another non-benzodiazepine sedative-hypnotic. Much less potent than its counterparts, Ambien and Lunesta, Sonata is typically prescribed to people who have trouble falling asleep as opposed to people who need help staying asleep. Though Sonata is said to be one of the least habit-forming and addictive sleeping pills, there is still a possibility of developing a physical and psychological dependence to the drug. Most users do not realize they have an addiction to Sonata until they stop taking the pill.
- Lunesta: Lunesta is the brand-name sleeping pill for eszopiclone, also a non-benzodiazepine sedative-hypnotic. A result of a recent surge in television publicity, Lunesta has established itself as one of the top three prescribed sleeping pills in the United States, with about 3 million Lunesta prescriptions being dispensed to Americans in 2013. Addiction to Lunesta can form in as little as two weeks with withdrawal symptoms being similar to benzodiazepine withdrawal, including potential risk for seizures, hallucinations, and suicidal thoughts.
- Amytal: Amytal, otherwise known by its generic version amobarbital, is a barbiturate used as a pre-anesthetic for surgeries and sometimes as a heavily regulated sleeping aide. It is distributed as a white powder that gets dissolved in water and injected into the user. Because Amytal is a barbiturate, addicted persons will need to go through a detox period for treatment.
- Temazepam (Restoril): Restoril, or temazepam, is a federally controlled substance (C-IV), a sedative-hypnotic that is used to treat insomnia. Used for both helping insomniacs fall asleep and prevent consistent waking up at night, Restoril is a product that people can easily develop a physical dependence and addiction to. Tolerance levels can adjust within three days, which is why Restoril is normally not prescribed longer than 7 to 10 days and is closely monitored by a doctor.
- Estazolam: Estazolam, marketed under the brand names ProSom and Eurodin, is an oral benzodiazepine commonly prescribed as a short-term sleeping pill. There is potential for abuse if people use estazolam to achieve a high and/or continue long-term use of the sleeping pill against medical instruction, and especially if mixed with other substances, such as alcohol. People who quit taking estazolam may experience benzodiazepine withdrawal symptoms and rebound insomnia.
- Phenobarbital: also known as phenobarbitone and sold under the brand name Luminal–is a prescription medication used to treat a number of conditions including seizure disorders, insomnia, tension and anxiety. Prolonged use of phenobarbital can be habit-forming, even at therapeutic doses, and result in a higher tolerance for the drug